Recently, we found activated signal transducer and activator of transcription 3 (STAT3) is upregulated by interleukin (IL)-6 and blocking of the STAT3/CD133/survivin signaling pathway showed anticancer effect in colon cancer in vitro [8, 10]. This evidence concerns the gene PROM1 and colonic neoplasm.